PubRank

B M Phillips

Author PubWeight™ 22.38‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Overdiagnosis of cystic fibrosis. Lancet 1982 1.69
2 Reversible absorptive defects in anticonvulsant megaloblastic anaemia. J Clin Pathol 1965 1.68
3 Extradural haematoma in a child after an apparently mild head injury. BMJ 1993 1.51
4 Pathogenesis and management of arthropathy in cystic fibrosis. J R Soc Med 1986 1.48
5 An evaluation of methods for calculating mean sediment quality guideline quotients as indicators of contamination and acute toxicity to amphipods by chemical mixtures. Environ Toxicol Chem 2001 1.23
6 A large-scale categorization of sites in San Francisco Bay, USA, based on the sediment quality triad, toxicity identification evaluations, and gradient studies. Environ Toxicol Chem 2001 1.12
7 Case of encephalitis due to herpes simplex. Br Med J 1966 1.09
8 In vitro assessment of anti-inflammatory activity. J Pharm Pharmacol 1967 1.07
9 Sediment quality in Los Angeles Harbor, USA: a triad assessment. Environ Toxicol Chem 2001 0.97
10 Psychiatric comorbidity among patients with hypochondriasis. Gen Hosp Psychiatry 1994 0.90
11 A case of paragonimiasis. Arch Dis Child 1978 0.89
12 Systemic toxicity of polyinosinic acid: polycytidylic acid in rodents and dogs. Toxicol Appl Pharmacol 1971 0.87
13 Integrated assessment of the impacts of agricultural drainwater in the Salinas River (California, USA). Environ Pollut 2003 0.87
14 Sedative, antiadrenergic, and hypotensive 2-substituted 2H-1,2,4-benzothiadiazin-3(4H)-one 1,1-dioxides. J Med Chem 1968 0.86
15 Identifying primary stressors impacting macroinvertebrates in the Salinas River (California, USA): relative effects of pesticides and suspended particles. Environ Pollut 2005 0.85
16 Evaluation of a tympanic thermometer in children. Lancet 1993 0.83
17 The validity of DSM-III-R hypochondriasis. Arch Gen Psychiatry 1993 0.83
18 One-year follow-up of medical outpatients with hypochondriasis. Psychosomatics 1995 0.82
19 Glycolytic enzymes in human brain. Biochem J 1964 0.81
20 Ceftazidime - a significant advance in the treatment of cystic fibrosis. J Antimicrob Chemother 1983 0.79
21 Oral contraceptive drugs and migraine. Br Med J 1968 0.79
22 The physical, animal and human pharmacologic, and toxicologic properties of desonide, a new, topically active, antiinflammatory steroid. Toxicol Appl Pharmacol 1971 0.79
23 Physician recognition of hypochondriacal patients. Gen Hosp Psychiatry 1996 0.78
24 Influence of sample manipulation on contaminant flux and toxicity at the sediment-water interface. Mar Environ Res 2001 0.78
25 Influence of salinity on copper and azide toxicity to larval topsmelt Atherinops affinis (Ayres). Arch Environ Contam Toxicol 1995 0.77
26 A comparison of in situ and laboratory toxicity tests with the estuarine amphipod Eohaustorius estuarius. Arch Environ Contam Toxicol 2004 0.75
27 Pituitary apoplexy presenting as multiple ocular nerve palsies of sudden onset. Br J Neurosurg 1994 0.75
28 Synthesis and antiinflammatory activity of some 1,2,3- and 1,2,4-triazolepropionic acids. J Med Chem 1978 0.75
29 Method for the evaluation of antihypertensive agents, including thiazide-type compounds. J Pharm Sci 1965 0.75
30 Simple assay for determination of carbonic anhydrase activity. J Pharm Sci 1969 0.75
31 Does aspirin play a role in analgesic nephropathy? Aust N Z J Med 1976 0.75
32 Cystic fibrosis: the challenge in research and management. Nurs Mirror 1978 0.75
33 Aspirin-induced gastrointestinal microbleeding in dogs. Toxicol Appl Pharmacol 1973 0.75
34 [Study of the pharmacology of the quipazine maleate. I. General pharmacology of quipazine maleate]. Gac Med Mex 1969 0.75
35 Improved colorimetric determination of aspirin and salicylic acid concentrations in human plasma. J Pharm Sci 1978 0.75
36 Spectrophotometric determination of a mixture of secondary and tertiary amines in urine. J Pharm Sci 1965 0.75
37 Antiinflammatory beta-arylamidoacrylic acids. J Med Chem 1975 0.75
38 Sodium lauryl sulphate/amphoteric surfactant interactions: selective diffusion through a collagen film. Int J Cosmet Sci 1991 0.75
39 Physical form as a determinant of effect of buffered acetylsalicylate formulations on gi microbleeding. J Pharm Sci 1977 0.75
40 Determination of the gastro-intestinal absorption of MA568, [4-(1-phenyl-4-piperazinyl) butyl 3,4,5-trimethoxybenzoate]. Arch Int Pharmacodyn Ther 1965 0.75
41 The influence of aspirin on gastrointestinal microbleeding in dogs with gastric ulcers. Am J Dig Dis 1976 0.75
42 A subchronic study of the toxicity of an orally administered benzoquinolizinyl derivative in the rat and dog. Toxicology 1975 0.75
43 The acute and target organ toxicity of 1-methyl-3-keto-4-phenylquinuclidinium bromide (MA540) and guanethidine in the rat and dog. Arzneimittelforschung 1976 0.75
44 Influence of aspirin formulation and dose on concentration of total salicylate in rat kidney. J Pharm Sci 1976 0.75
45 Determination of total salicylates, phenacetin and-or total N-acetyl-p-aminophenol, and caffeine in biological samples and analgesic formulations. J Pharm Sci 1973 0.75
46 Simultaneous extraction of tissue norepinephrine and serotonin. J Pharm Sci 1969 0.75
47 Ring opening of cyclic salicylamides. J Pharm Sci 1969 0.75
48 Causes of ambient toxicity in the Calleguas Creek watershed of southern California. Environ Monit Assess 2002 0.75
49 A method of evaluation of the influence of aspirin formulations on gastrointestinal microbleeding in humans. Toxicol Appl Pharmacol 1971 0.75
50 The influence of ocular instillation of phosphate buffer on intraocular pressure in rabbits. Toxicol Appl Pharmacol 1970 0.75
51 Evaluation and use of sediment toxicity reference sites for statistical comparisons in regional assessments. Environ Toxicol Chem 2001 0.75
52 Biological disposition of 2-(4-phenyl-1-piperazinylmethyl)cyclohexanone-1-C-14 (C-14-MA1050). J Pharm Sci 1965 0.75